175 related articles for article (PubMed ID: 19486858)
1. Mutational spectrum of conserved regions of TP53 and PTEN genes in Kangri cancer (of the skin) in the Kashmiri population.
Hussain I; ul Rehman S; Afroze D; Zahoor L; Abdullah S; Hafiz A; Shah ZA; Iqbal S; Shaffi M; Das BC; Siddiqi MA
Mutat Res; 2009 May; 676(1-2):5-10. PubMed ID: 19486858
[TBL] [Abstract][Full Text] [Related]
2. BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area.
Eachkoti R; Hussain I; Afroze D; Aejazaziz S; Jan M; Shah ZA; Das BC; Siddiqi MA
Cancer Lett; 2007 Apr; 248(2):308-20. PubMed ID: 16996204
[TBL] [Abstract][Full Text] [Related]
3. Impact of codon 72 Arg > Pro single nucleotide polymorphism in TP53 gene in the risk of kangri cancer: a case control study in Kashmir.
Pandith AA; Khan NP; Rashid N; Azad N; Zaroo I; Hafiz A; Siddiqi MA
Tumour Biol; 2012 Aug; 33(4):927-33. PubMed ID: 22249977
[TBL] [Abstract][Full Text] [Related]
4. Polymorphic analysis of MHClinked Heat Shock Protein 70 genes: Their susceptibility and prognostic implication in Kangri cancer cases of Kashmiri population.
Rehman SU; Sameer AS; Zahoor L; Syeed N; Nanda MS; Hafiz A; Shah ZA; Siddiqi MA
Indian J Hum Genet; 2009 May; 15(2):65-71. PubMed ID: 20680154
[TBL] [Abstract][Full Text] [Related]
5. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis.
de Anta JM; Jassem E; Rosell R; Martínez-Roca M; Jassem J; Martínez-López E; Monzó M; Sánchez-Hernández JJ; Moreno I; Sánchez-Céspedes M
Oncogene; 1997 Dec; 15(24):2951-8. PubMed ID: 9416838
[TBL] [Abstract][Full Text] [Related]
6. TP53 - molecular soldier's mutations in bladder cancer in the Kashmiri population.
Nanda MS; Shah ZA; Sameer AS; Syeed N; Murtaza I; Siddiqi MA; Ali A
Asian Pac J Cancer Prev; 2011; 12(1):67-72. PubMed ID: 21517233
[TBL] [Abstract][Full Text] [Related]
7. High mutation frequency at Ha-ras exons 1-4 in squamous cell carcinomas from PUVA-treated psoriasis patients.
Kreimer-Erlacher H; Seidl H; Bäck B; Kerl H; Wolf P
Photochem Photobiol; 2001 Aug; 74(2):323-30. PubMed ID: 11547572
[TBL] [Abstract][Full Text] [Related]
8. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
9. Characterization of p53 gene mutations in a Brazilian population with oral squamous cell carcinomas.
Chaves AC; Cherubini K; Herter N; Furian R; Santos DS; Squier C; Domann FE
Int J Oncol; 2004 Feb; 24(2):295-303. PubMed ID: 14719105
[TBL] [Abstract][Full Text] [Related]
10. Patches of mutant p53-immunoreactive epidermal cells induced by chronic UVB Irradiation harbor the same p53 mutations as squamous cell carcinomas in the skin of hairless SKH-1 mice.
Kramata P; Lu YP; Lou YR; Singh RN; Kwon SM; Conney AH
Cancer Res; 2005 May; 65(9):3577-85. PubMed ID: 15867351
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
Walsh T; Casadei S; Coats KH; Swisher E; Stray SM; Higgins J; Roach KC; Mandell J; Lee MK; Ciernikova S; Foretova L; Soucek P; King MC
JAMA; 2006 Mar; 295(12):1379-88. PubMed ID: 16551709
[TBL] [Abstract][Full Text] [Related]
12. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR
Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120
[TBL] [Abstract][Full Text] [Related]
13. Mutational and expressional analyses of PTEN gene in colorectal cancer from Northern India.
Ali A; Saluja SS; Hajela K; Mishra PK; Rizvi MA
Mol Carcinog; 2014 Feb; 53 Suppl 1():E45-52. PubMed ID: 23359334
[TBL] [Abstract][Full Text] [Related]
14. TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma.
Russo A; Corsale S; Agnese V; Macaluso M; Cascio S; Bruno L; Surmacz E; Dardanoni G; Valerio MR; Vieni S; Restivo S; Fulfaro F; Tomasino RM; Gebbia N; Bazan V
J Cell Physiol; 2006 Jan; 206(1):181-8. PubMed ID: 15965904
[TBL] [Abstract][Full Text] [Related]
15. Novel mutations of the suppressor gene PTEN in colorectal carcinomas stratified by microsatellite instability- and TP53 mutation- status.
Danielsen SA; Lind GE; Bjørnslett M; Meling GI; Rognum TO; Heim S; Lothe RA
Hum Mutat; 2008 Nov; 29(11):E252-62. PubMed ID: 18781614
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
17. p53 alterations in chemically induced hamster cheek-pouch lesions.
Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E
Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462
[TBL] [Abstract][Full Text] [Related]
18. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
[TBL] [Abstract][Full Text] [Related]
19. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
20. Mutational profiling of familial male breast cancers reveals similarities with luminal A female breast cancer with rare TP53 mutations.
Deb S; Wong SQ; Li J; Do H; Weiss J; Byrne D; Chakrabarti A; Bosma T; ; Fellowes A; Dobrovic A; Fox SB
Br J Cancer; 2014 Dec; 111(12):2351-60. PubMed ID: 25490678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
